tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
IMAB is currently covered by 3 analysts with an average price target of $15.31. This is a potential upside of $10.36 (209.29%) from yesterday's end of day stock price of $4.95.
I-Mab's activity chart (see below) currently has 20 price targets and 39 ratings on display. The stock rating distribution of IMAB is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 56.43% with an average time for these price targets to be met of 158.2 days.
Highest price target for IMAB is $6, Lowest price target is $6, average price target is $6.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 08-Sep-2025. First documented stock forecast 11-Feb-2020.
Currently out of the existing stock ratings of IMAB, 8 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$6
$1.05 (21.21%)
$5
1 months 25 days ago
(08-Sep-2025)
4/7 (57.14%)
$1.73 (40.52%)
168
Buy
6 months 29 days ago
(04-Apr-2025)
1/4 (25%)
$6.19 (341.99%)
85
Buy
$5
$0.05 (1.01%)
$16
1 years 8 months 21 days ago
(12-Feb-2024)
2/2 (100%)
$3.2 (177.78%)
314
Buy
2 years 1 months 28 days ago
(05-Sep-2023)
3/4 (75%)
$13.97 (18.37%)
133
Buy
$35
2 years 6 months 30 days ago
(03-Apr-2023)
1/4 (25%)
$26.73 (323.22%)
91
What is IMAB (I-Mab) average time for price targets to be met?
Which analyst has the current highest performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the current lower performing score on IMAB (I-Mab) with a proven track record?
Which analyst has the most public recommendations on IMAB (I-Mab)?
Which analyst is the currently most bullish on IMAB (I-Mab)?
Which analyst is the currently most reserved on IMAB (I-Mab)?
